איסטודקס - Istodax

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L01XH
Histone deacetylase (HDAC) inhibitors

××¨××× ×¤×¢×× (ATC5)

Romidepsin 10 MG/VIAL âL01XH02

×¦××¨×ª ××ª×

×ª××-××¨××× - I.V

×¦××¨×ª ××× ××

×××§× ××××× ×××× ×ª ×ª×××¡× ××××¨×§×, POWDER AND DILUENT FOR SOLUTION FOR INJECTION
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

â¢ Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.â¢ Treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

09/01/2013

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××××¤××× ××¡×× CTCL (Cutaneous T cell lymphoma) ××§× ×××¤×× ××ª×§×× (××××¨ ×××¤×× ×¡××¡××× ××× ××¤×××ª).
××××¤××× ××¡×× PTCL (Peripheral T cell lymphoma) ××§× ×××¤×× ××ª×§×× (×©×××©× ×××××).

×©××××© ××¡×

××¡××¨×ª ××××× ××¡×

×. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×××§×¨×× ××××:

2. ××××¤××× ××¡×× CTCL (Cutaneous T cell lymphoma) ××§× ×××¤×× ××ª×§×× (××××¨ ×××¤×× ×¡××¡××× ××× ××¤×××ª).

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 30.09.2021
××××¨× ××¢××× ××¨××¤× 22.01.2015 (××¡×× Microsoft Word)

××××¨× ××¢××× 30.09.2021

×¢××× ××¦×¨××	Â

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××¡××××§×¡ ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	CELGENE INTERNATIONAL SARL, SWITZERLAND
×©× ××¢× ××¨××©××	NEOPHARM SCIENTIFIC LTD
×¨××©×××	×ª××¨×× ×××©×: 07/2012. ×¨××©××× ××ª××¨××: 10/2018
×ª××¨×× ×¢×××× ×××¨××	14/05/19

השינוי האחרון נעשה בֹ־8 בספטמבר 2025 ב־04:20

איסטודקס - Istodax

ויקיתרופות